Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Dudakova A, Spiess B, Tangwattanachuleeporn M, Sasse C, Buchheidt D, Weig M, Groß U, Bader O.

Clin Microbiol Rev. 2017 Oct;30(4):1065-1091. doi: 10.1128/CMR.00095-16. Review.

2.

Oral findings and dental behaviour before and after liver transplantation - a single-centre cross-sectional study.

Kauffels A, Schmalz G, Kollmar O, Slotta JE, Weig M, Groß U, Bader O, Ziebolz D.

Int Dent J. 2017 Aug;67(4):244-251. doi: 10.1111/idj.12290. Epub 2017 Mar 10.

PMID:
28295299
3.

Diversity and Antifungal Drug Susceptibility of Cryptococcus Isolates in Thailand.

Worasilchai N, Tangwattanachuleeporn M, Meesilpavikkai K, Folba C, Kangogo M, Groß U, Weig M, Bader O, Chindamporn A.

Med Mycol. 2017 Aug 1;55(6):680-685. doi: 10.1093/mmy/myw130.

PMID:
27915307
4.

Subtyping of Campylobacter jejuni ssp. doylei Isolates Using Mass Spectrometry-based PhyloProteomics (MSPP).

Zautner AE, Lugert R, Masanta WO, Weig M, Groß U, Bader O.

J Vis Exp. 2016 Oct 30;(116). doi: 10.3791/54165.

5.

Towards proteomic species barcoding of fungi - An example using Scedosporium/Pseudallescheria complex isolates.

Bernhard M, Zautner AE, Steinmann J, Weig M, Groß U, Bader O.

Fungal Biol. 2016 Feb;120(2):162-5. doi: 10.1016/j.funbio.2015.07.001. Epub 2015 Jul 17.

PMID:
26781372
6.

Aspergillus oerlinghausenensis, a new mould species closely related to A. fumigatus.

Houbraken J, Weig M, Groß U, Meijer M, Bader O.

FEMS Microbiol Lett. 2016 Feb;363(3). pii: fnv236. doi: 10.1093/femsle/fnv236. Epub 2015 Dec 13.

PMID:
26667219
7.

Proteomic analysis of hyperadhesive Candida glabrata clinical isolates reveals a core wall proteome and differential incorporation of adhesins.

Gómez-Molero E, de Boer AD, Dekker HL, Moreno-Martínez A, Kraneveld EA, Ichsan, Chauhan N, Weig M, de Soet JJ, de Koster CG, Bader O, de Groot PW.

FEMS Yeast Res. 2015 Dec;15(8). pii: fov098. doi: 10.1093/femsyr/fov098. Epub 2015 Nov 5.

PMID:
26546455
8.

Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.

Kangogo M, Bader O, Boga H, Wanyoike W, Folba C, Worasilchai N, Weig M, Groß U, Bii CC.

Mycoses. 2015 Nov;58(11):665-70. doi: 10.1111/myc.12411. Epub 2015 Sep 25.

PMID:
26404188
9.

Mass Spectrometry-based PhyloProteomics (MSPP): A novel microbial typing Method.

Zautner AE, Masanta WO, Weig M, Groß U, Bader O.

Sci Rep. 2015 Aug 25;5:13431. doi: 10.1038/srep13431.

10.

Environmental isolates of azole-resistant Aspergillus fumigatus in Germany.

Bader O, Tünnermann J, Dudakova A, Tangwattanachuleeporn M, Weig M, Groß U.

Antimicrob Agents Chemother. 2015 Jul;59(7):4356-9. doi: 10.1128/AAC.00100-15. Epub 2015 May 4.

11.

Yeast on-target lysis (YOTL), a procedure for making auxiliary mass spectrum data sets for clinical routine identification of yeasts.

Bernhard M, Weig M, Zautner AE, Groß U, Bader O.

J Clin Microbiol. 2014 Dec;52(12):4163-7. doi: 10.1128/JCM.02128-14. Epub 2014 Sep 17.

12.

[Incidence of Candidaemia Following Abdominal Surgery in German Hospitals].

Kuhns M, Rosenberger A, Bader O, Reichard U, Gross U, Weig M.

Zentralbl Chir. 2015 Dec;140(6):617-23. doi: 10.1055/s-0033-1350814. Epub 2013 Nov 15. German.

PMID:
24241950
13.

Discrimination of multilocus sequence typing-based Campylobacter jejuni subgroups by MALDI-TOF mass spectrometry.

Zautner AE, Masanta WO, Tareen AM, Weig M, Lugert R, Groß U, Bader O.

BMC Microbiol. 2013 Nov 7;13:247. doi: 10.1186/1471-2180-13-247.

14.

Prevalence and antifungal susceptibility of Cryptococcus neoformans isolated from pigeon excreta in Chon Buri Province, Eastern Thailand.

Tangwattanachuleeporn M, Somparn P, Poolpol K, Gross U, Weig M, Bader O.

Med Mycol J. 2013;54(3):303-7.

15.

Soybean toxin (SBTX) impairs fungal growth by interfering with molecular transport, carbohydrate/amino acid metabolism and drug/stress responses.

Morais JK, Bader O, Weig M, Oliveira JT, Arantes MR, Gomes VM, Da Cunha M, Oliveira HD, Sousa DO, Lourencao AL, Vasconcelos IM.

PLoS One. 2013 Jul 22;8(7):e70425. doi: 10.1371/journal.pone.0070425. Print 2013.

16.

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.

Bader O, Weig M, Reichard U, Lugert R, Kuhns M, Christner M, Held J, Peter S, Schumacher U, Buchheidt D, Tintelnot K, Groß U; MykoLabNet-D Partners.

Antimicrob Agents Chemother. 2013 Aug;57(8):3513-7. doi: 10.1128/AAC.00167-13. Epub 2013 May 13.

17.

Adhesins in human fungal pathogens: glue with plenty of stick.

de Groot PW, Bader O, de Boer AD, Weig M, Chauhan N.

Eukaryot Cell. 2013 Apr;12(4):470-81. doi: 10.1128/EC.00364-12. Epub 2013 Feb 8. Review.

18.

Gross karyotypic and phenotypic alterations among different progenies of the Candida glabrata CBS138/ATCC2001 reference strain.

Bader O, Schwarz A, Kraneveld EA, Tangwattanachuleeporn M, Schmidt P, Jacobsen MD, Gross U, De Groot PW, Weig M.

PLoS One. 2012;7(12):e52218. doi: 10.1371/journal.pone.0052218. Epub 2012 Dec 20. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/b929fe83-8e7f-4e8a-986e-9a3e26d86c54. Tangwattanchuleeporn, Marut [corrected to Tangwattanachuleeporn, Marut].

19.

Glycosylation of Candida albicans cell wall proteins is critical for induction of innate immune responses and apoptosis of epithelial cells.

Wagener J, Weindl G, de Groot PW, de Boer AD, Kaesler S, Thavaraj S, Bader O, Mailänder-Sanchez D, Borelli C, Weig M, Biedermann T, Naglik JR, Korting HC, Schaller M.

PLoS One. 2012;7(11):e50518. doi: 10.1371/journal.pone.0050518. Epub 2012 Nov 30.

20.

Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.

Hull CM, Bader O, Parker JE, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL.

Antimicrob Agents Chemother. 2012 Dec;56(12):6417-21. doi: 10.1128/AAC.01145-12. Epub 2012 Oct 1.

21.

Rapid discrimination of Salmonella enterica serovar Typhi from other serovars by MALDI-TOF mass spectrometry.

Kuhns M, Zautner AE, Rabsch W, Zimmermann O, Weig M, Bader O, Groß U.

PLoS One. 2012;7(6):e40004. doi: 10.1371/journal.pone.0040004. Epub 2012 Jun 29.

22.

Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.

Hull CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL.

Antimicrob Agents Chemother. 2012 Aug;56(8):4223-32. doi: 10.1128/AAC.06253-11. Epub 2012 May 21.

23.

Photo quiz. A 32-year-old man with ulcerative mucositis, skin lesions, and nail dystrophy. Chronic mucocutaneous candidiasis by multidrug-resistant Candida albicans.

Bader O, Weig MS, Gross U, Schön MP, Mempel M, Buhl T.

Clin Infect Dis. 2012 Apr;54(7):972, 1035-6. doi: 10.1093/cid/cir958. No abstract available.

PMID:
22403094
24.

Mucocutaneous candidiasis in a mandrill (Mandrillus sphinx).

Zöller M, Silinski S, Ludwig C, Weig M, Mätz-Rensing K, Kaup FJ.

J Comp Pathol. 2012 Aug-Oct;147(2-3):381-5. doi: 10.1016/j.jcpa.2011.11.197. Epub 2012 Jan 31.

PMID:
22300706
25.

Interlaboratory comparison of PCR-based identification of Candida and Aspergillus DNA in spiked blood samples.

Reichard U, Buchheidt D, Lass-Flörl C, Loeffler J, Lugert R, Ruhnke M, Tintelnot K, Weig M, Groß U.

Mycoses. 2012 Sep;55(5):426-34. doi: 10.1111/j.1439-0507.2011.02167.x. Epub 2012 Jan 16.

PMID:
22248125
26.

Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases.

Däbritz J, Attarbaschi A, Tintelnot K, Kollmar N, Kremens B, von Loewenich FD, Schrod L, Schuster F, Wintergerst U, Weig M, Lehrnbecher T, Groll AH.

Mycoses. 2011 Nov;54(6):e785-8. doi: 10.1111/j.1439-0507.2011.02025.x. Epub 2011 May 30.

PMID:
21623951
27.

Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M.

Clin Microbiol Infect. 2011 Sep;17(9):1359-65. doi: 10.1111/j.1469-0691.2010.03398.x. Epub 2010 Dec 3.

28.

Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.

Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Rolley N, Kelly DE, Kelly SL.

Antimicrob Agents Chemother. 2010 Nov;54(11):4527-33. doi: 10.1128/AAC.00348-10. Epub 2010 Aug 23.

29.

A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.

Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL.

Antimicrob Agents Chemother. 2010 Sep;54(9):3578-83. doi: 10.1128/AAC.00303-10. Epub 2010 Jun 14.

30.

The Candida albicans cell wall protein Rhd3/Pga29 is abundant in the yeast form and contributes to virulence.

de Boer AD, de Groot PW, Weindl G, Schaller M, Riedel D, Diez-Orejas R, Klis FM, de Koster CG, Dekker HL, Gross U, Bader O, Weig M.

Yeast. 2010 Aug;27(8):611-24. doi: 10.1002/yea.1790.

31.

The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins.

de Groot PW, Kraneveld EA, Yin QY, Dekker HL, Gross U, Crielaard W, de Koster CG, Bader O, Klis FM, Weig M.

Eukaryot Cell. 2008 Nov;7(11):1951-64. doi: 10.1128/EC.00284-08. Epub 2008 Sep 19.

32.

[At the limits of the host--the cell wall of human pathogenic yeasts].

Weig M.

Mycoses. 2008 Sep;51 Suppl 3:26-9. doi: 10.1111/j.1439-0507.2008.01583.x. German. No abstract available.

PMID:
18782241
33.

Proteomic analysis of the pH response in the fungal pathogen Candida glabrata.

Schmidt P, Walker J, Selway L, Stead D, Yin Z, Enjalbert B, Weig M, Brown AJ.

Proteomics. 2008 Feb;8(3):534-44. doi: 10.1002/pmic.200700845.

PMID:
18186024
34.

Mid-cycle serum levels of endogenous LH are not associated with the likelihood of pregnancy in artificial frozen-thawed embryo transfer cycles without pituitary suppression.

Griesinger G, Weig M, Schroer A, Diedrich K, Kolibianakis EM.

Hum Reprod. 2007 Oct;22(10):2589-93. Epub 2007 Jul 25.

PMID:
17652451
35.

Genomics and the development of new diagnostics and anti-Candida drugs.

Weig M, Brown AJ.

Trends Microbiol. 2007 Jul;15(7):310-7. Epub 2007 Jun 14. Review.

PMID:
17570672
36.

Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.

Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U.

J Antimicrob Chemother. 2007 Aug;60(2):424-8. Epub 2007 Jun 11.

PMID:
17562683
37.

Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli.

Dasti JI, Gross U, Pohl S, Lugert R, Weig M, Schmidt-Ott R.

J Med Microbiol. 2007 Jun;56(Pt 6):833-7.

PMID:
17510271
38.

Mass spectrometric identification of covalently bound cell wall proteins from the fission yeast Schizosaccharomyces pombe.

de Groot PW, Yin QY, Weig M, Sosinska GJ, Klis FM, de Koster CG.

Yeast. 2007 Apr;24(4):267-78.

39.

Candida and Candidosis today: where are we, and where to go? The Interdisciplinary Forum on Candidosis (IFOCAN) 2005, Göttingen (Germany), 23-25 September 2005.

Kaplanek P, de Boer A, Gross U, de Groot P, Hube B, Weig M.

FEMS Yeast Res. 2006 Dec;6(8):1290-4. No abstract available.

40.

Analysis of the major proteins secreted by the human opportunistic pathogen Aspergillus fumigatus under in vitro conditions.

Schwienbacher M, Weig M, Thies S, Regula JT, Heesemann J, Ebel F.

Med Mycol. 2005 Nov;43(7):623-30.

PMID:
16396247
41.

Identification and characterization of a major subgroup of conjugative Campylobacter jejuni plasmids.

Schmidt-Ott R, Pohl S, Burghard S, Weig M, Gross U.

J Infect. 2005 Jan;50(1):12-21.

PMID:
15603835
42.

Systematic identification in silico of covalently bound cell wall proteins and analysis of protein-polysaccharide linkages of the human pathogen Candida glabrata.

Weig M, Jänsch L, Gross U, De Koster CG, Klis FM, De Groot PW.

Microbiology. 2004 Oct;150(Pt 10):3129-44.

PMID:
15470094
43.

Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children.

Müller FM, Trusen A, Weig M.

Eur J Pediatr. 2002 Nov;161(11):563-74. Epub 2002 Sep 11. Review.

PMID:
12424579
44.

Human deep tissue infection with an entomopathogenic Beauveria species.

Henke MO, De Hoog GS, Gross U, Zimmermann G, Kraemer D, Weig M.

J Clin Microbiol. 2002 Jul;40(7):2698-702.

45.

Congress report. Aspergillus fumigatus--virulence and opportunism?

Weig M, Reichard U, Gross U.

Mycoses. 2001 Nov;44(9-10):351-5. No abstract available.

PMID:
11766097
46.

A GAS-like gene family in the pathogenic fungus Candida glabrata.

Weig M, Haynes K, Rogers TR, Kurzai O, Frosch M, Mühlschlegel FA.

Microbiology. 2001 Aug;147(Pt 8):2007-19.

PMID:
11495979
47.

Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases.

Weig M, Frosch M, Tintelnot K, Haas A, Gross U, Linsmeier B, Heesemann J.

J Clin Microbiol. 2001 May;39(5):1721-30.

49.

Evaluation of the intestinal microflora in the rat model for esophageal adenocarcinoma.

Fein M, Fuchs KH, DeMeester TR, Peters JH, Wittmann D, Weig M.

Dis Esophagus. 2000;13(1):39-43.

PMID:
11005330
50.

Supplemental Content

Support Center